NRx Pharmaceuticals Inc.
0.25
0.00 (0.00%)
At close: Jan 15, 2025, 12:33 PM
0.24
-3.17%
After-hours Jan 15, 2025, 12:57 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -30.15M -39.75M -93.06M -51.78M 408.43K 66.10K -105.03K
Depreciation & Amortization 5.00K 4.00K 2.00K 2.00K 0.86 n/a n/a
Stock-Based Compensation 387.00K 3.63M 7.79M 730.00K 933.90 n/a n/a
Other Working Capital 2.51M 2.31M -5.71M 3.10M -66.68K 84.20K -87.00K
Other Non-Cash Items 2.94M -4.33M 54.28M 39.61M -1.28M -1.55M -115.11K
Deferred Income Tax n/a n/a -1.81M 5.72M 70.41K n/a n/a
Change in Working Capital 5.16M 699.00K -4.90M 3.45M 4.66K 549.63K -1.33K
Operating Cash Flow -21.66M -39.76M -37.70M -2.27M -792.73K -473.19K -135.81K
Capital Expenditures -3.00K -10.00K -7.00K -2.00K -3.55 n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a -10.00K -7.00K n/a -993.10K -690.00K -69.00M
Sales Maturities Of Investments n/a n/a n/a n/a 41.24M 42.39K n/a
Other Investing Acitivies n/a 10.00K 7.00K 26.18M 3.55 -647.61K -69.00M
Investing Cash Flow -3.00K -10.00K -7.00K -2.00K 40.25M -647.61K -69.00M
Debt Repayment -3.09M 9.50M n/a 620.00K n/a 690.00K n/a
Common Stock Repurchased n/a n/a n/a n/a -40.73M n/a 70.03M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.17M 22.71M 26.47M 50.00K 1.26M n/a n/a
Financial Cash Flow 6.20M 32.21M 63.46M 3.25M -39.46M 682.50K 69.59M
Net Cash Flow -15.46M -7.55M 25.75M 982.00K -11.07K -438.30K 449.37K
Free Cash Flow -21.66M -39.77M -37.71M -2.27M -792.73K -473.19K -135.81K

Create Price Alert on NRXPW

Your price alert will notify you when the stock price is above 0.25.

Add to Watchlist